334
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy of Biosimilar Adalimumab in the Treatment of Behçet’s Uveitis

, MDORCID Icon, , MDORCID Icon, , MDORCID Icon, , MDORCID Icon, , MDORCID Icon & , PharmD
Pages 1495-1500 | Received 18 Aug 2020, Accepted 01 Mar 2021, Published online: 07 Apr 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

GM Murray, N Griffith, P Sinnappurajar, DA Al Julandani, SLN Clarke, DP Hawley, J Choi, CM Guly & Athimalaipet V Ramanan. (2023) Clinical Efficacy of Biosimilar Switch of Adalimumab for Management of Uveitis. Ocular Immunology and Inflammation 0:0, pages 1-5.
Read now
Hidayet Sener, Cem Evereklioglu, Fatih Horozoglu & Ayse Busra Gunay Sener. (2023) Efficacy and Safety of Adalimumab in Patients with Behçet Uveitis: A Systematic Review and Meta-Analysis. Ocular Immunology and Inflammation 0:0, pages 1-9.
Read now

Articles from other publishers (1)

Nicola Humphry. (2022) The Rise of Anti-TNF Biosimilars: Guidelines, Real-World Evidence, and Challenges to Acceptance. EMJ Gastroenterology, pages 2-10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.